Actively Recruiting
GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
Led by Beijing Tongren Hospital · Updated on 2024-06-21
340
Participants Needed
1
Research Sites
137 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate whether goal-directed fluid therapy (GDFT) can improve the postoperative recovery in patients undergoing head and neck cancer surgery. It aims to answer is: • Whether GDFT can reduce the occurrence of serious postoperative complications? Researchers will compare GDFT protocol to a standard conventional fluid therapy in head and neck cancer surgery to see if GDFT strategy works to improve the postoperative recovery. Participants will * Receive GDFT protocol or a conventional fluid therapy during the surgery. * Be continuously follow-up during hospitalization and after discharge to record the occurrence of postoperative complications.
CONDITIONS
Official Title
GDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Scheduled for head and neck cancer surgery (including nasopharyngeal carcinoma, laryngocarcinoma, hypopharyngeal carcinoma, and other head and neck malignancies, excluding thyroid cancer) lasting 2 hours or more
- Agree to receive invasive artery blood pressure monitoring during surgery
You will not qualify if you...
- American Society of Anesthesiologists (ASA) classification higher than III
- Undergoing palliative surgery for terminal tumors
- Planned microlaryngoscopic laser surgery or endoscopic surgery
- Major thoracic or abdominal surgery within the past 30 days
- Require regular renal replacement therapy
- Have NYHA grade above 3 or ejection fraction below 30%
- Lung disease that does not tolerate tidal volume of 8 ml/kg
- Have atrial fibrillation
- Unable to provide informed consent
- Pregnant or lactating women
- Emergency surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
Research Team
X
Xuan Liang, master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here